Publication:
Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: Reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus

dc.contributor.authorSumana Dakengen_US
dc.contributor.authorSuwit Duangmanoen_US
dc.contributor.authorWeena Jiratchariyakulen_US
dc.contributor.authorYaowalak U-Pratyaen_US
dc.contributor.authorOliver Bögleren_US
dc.contributor.authorPimpicha Patmasiriwaten_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of Texas MD Anderson Cancer Centeren_US
dc.date.accessioned2018-06-11T04:40:26Z
dc.date.available2018-06-11T04:40:26Z
dc.date.issued2012-01-01en_US
dc.description.abstractThe cucurbitacins are tetracyclic triterpenes found in plants of the family Cucurbitaceae. Cucurbitacins have been shown to have anti-cancer and anti-inflamatory activities. We investigated the anti-cancer activity of cucurbitacin B extracted from Thai medicinal plant Trichosanthes cucumerina Linn. Cell viability was assessed by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide) assay. Results indicated that cucurbitacin B from T. cucumerina Linn. has a cytotoxic effect on breast cancer cell lines SKBR-3 and MCF-7 with an IC50 of 4.60 and 88.75 μg/ml, respectively. Growth inhibition was attributed to G2/M phase arrest and apoptosis. Cyclin D1, c-Myc, and β-catenin expression levels were reduced. Western blot analysis showed increased PARP cleavage and decreased Wnt-associated signaling molecules β-catenin, galectin-3, cyclin D1 and c-Myc, and corresponding changes in phosphorylated GSK-3β levels. Cucurbitacin B treatment inhibited translocation to the nucleus of β-catenin and galectin-3. The depletion of β-catenin and galectin-3 in the nucleus was confirmed by cellular protein fractionation. T-cell factor (TCF)/lymphoid enhancer factor (LEF)-dependent transcriptional activity was disrupted in cucurbitacin B treated cells as tested by a TCF reporter assay. The relative luciferase activity was reduced when we treated cells with cucurbitacin B compound for 24 h. Our data suggest that cucurbitacin B may in part induce apoptosis and exert growth inhibitory effect via interruption the Wnt signaling. Copyright © 2011 Wiley Periodicals, Inc.en_US
dc.identifier.citationJournal of Cellular Biochemistry. Vol.113, No.1 (2012), 49-60en_US
dc.identifier.doi10.1002/jcb.23326en_US
dc.identifier.issn10974644en_US
dc.identifier.issn07302312en_US
dc.identifier.other2-s2.0-84055222706en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/13854
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84055222706&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleInhibition of Wnt signaling by cucurbitacin B in breast cancer cells: Reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleusen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84055222706&origin=inwarden_US

Files

Collections